Search for information about a product,
therapeutic area or event

Media, investors, advocacy organizations and others, please contact us here.

Posters

Genetic Testing Identified Causative Variants in Nearly 20% of Early-Onset Bilateral Cataracts Cases

Posters

Long-Term Efficacy and Safety of Sparsentan in Young Patients WithFSGS: 240-Week Analysis of the DUET Open-Label Extension (OLE)

Posters

Sparsentan Publications 2023

Posters HCU

Population-based Incidence Estimates of Classical Homocystinuria Using the Genome Aggregation Database (gnomAD)

Posters HCU

A Longitudinal Study of Cognitive Function in Classical Homocystinuria (HCU) Demonstrates Distinct Deficits in Inhibitory Control

Posters HCU

Insights from the First Genetic Evaluation of a Longitudinal Natural History Study in Classical Homocystinuria (HCU)

Posters HCU

Population-based Incidence Estimates of Classical Homocystinuria Using the Genome Aggregation Database (gnomAD)

Posters HCU

A Longitudinal Study of Cognitive Function in Classical Homocystinuria (HCU) Demonstrates Distinct Deficits in Inhibitory Control

Posters HCU

Insights from the First Genetic Evaluation of a Longitudinal Natural History Study in Classical Homocystinuria (HCU)

Posters HCU

Pegtibatinase, an Investigational Enzyme Replacement Therapy for the Treatment of Classical Homocystinuria: Initial Results From the Phase 1/2 COMPOSE Study

Posters HCU

Pegtibatinase, an Investigational Enzyme Replacement Therapy for the Treatment of Classical Homocystinuria: Initial Results from the Phase 1/2 COMPOSE Study

Posters HCU

Dietary Goals and Current Challenges in the Management of Classical Homocystinuria: Insights From Multinational Real-World Experience

Posters

Sparsentan, the dual endothelin and angiotensin receptor antagonist (DEARA), improves kidney function and lifespan and protects against hearing loss in Alport mice with developed renal structural changes